CLR1501
Modify Date: 2024-01-31 18:38:54
CLR1501 structure
|
Common Name | CLR1501 | ||
|---|---|---|---|---|
| CAS Number | 1250963-36-0 | Molecular Weight | 701.674 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C38H59BF2N3O4P | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of CLR1501CLR1501, a fluorescently labeled CLR1404 analog, is a cancer cell-selective fluorescence compound[1][2]. |
| Name | Difluoro[2-({hydroxy[(18-{4-[(1H-pyrrol-2-yl-κN)(2H-pyrrol-2-ylidene-κN)methyl]phenyl}octadecyl)oxy]phosphoryl}oxy)-N,N,N-trimethylethanaminiumato(2-)]boron |
|---|---|
| Synonym | More Synonyms |
| Description | CLR1501, a fluorescently labeled CLR1404 analog, is a cancer cell-selective fluorescence compound[1][2]. |
|---|---|
| Related Catalog | |
| In Vitro | CLR1501 exhibits five- to ninefold preferential uptake in these cancer cell lines in vitro compared to normal fibroblasts[1]. Excitation/emission peaks are 500/517 nm for CLR1501. CLR1501 exhibits tumor selectivity in vitro and in vivo for human glioblastoma stem-like (GSC) cell lines and xenografts[2]. |
| References |
| Molecular Formula | C38H59BF2N3O4P |
|---|---|
| Molecular Weight | 701.674 |
| Exact Mass | 701.430420 |
| Boron(1+), difluoro[2-[[hydroxy[[18-[4-[(1H-pyrrol-2-yl-κN)(2H-pyrrol-2-ylidene-κN)methyl]phenyl]octadecyl]oxy]phosphinyl]oxy]-N,N,N-trimethylethanaminiumato, inner salt]-, inner salt |
| Difluoro[2-({hydroxy[(18-{4-[(1H-pyrrol-2-yl-κN)(2H-pyrrol-2-ylidene-κN)methyl]phenyl}octadecyl)oxy]phosphoryl}oxy)-N,N,N-trimethylethanaminiumato(2-)]boron |
| CLR1501 |